Sign up for the premium plan and unlock all options
After purchasing the premium plan, you will unlock all information about drug prices and their availability.
Search
Listing 62021 - 62040 out of 495987 entries
| Country | ATC | Drug name | Drug form, strength, package | Price level | Price in € | Price in local currency | Therapeutic areas | Manufacturer / Importer |
|---|---|---|---|---|---|---|---|---|
| Brasil | (L01EX01) sunitinib (adm: O) | SUTENT | 25 MG CAP DURA CT FR PLAS PEAD OPC X 28 | Wholesale price without vat |
$0-0 |
$0-0 |
Gastrointestinal Stromal Tumors;Carcinoma, Renal Cell;Neuroendocrine Tumors | PFIZERBRASILLTDA |
| Brasil | (L01EX01) sunitinib (adm: O) | MALATO DE SUNITINIBE | 50 MG CAP DURA CT BL AL PLAS PVC/PE/PVDC TRANS X 28 | Wholesale price without vat |
$0-0 |
$0-0 |
n/a | NATCOFARMADOBRASILLTDA |
| Brasil | (L01EX01) sunitinib (adm: O) | MALATO DE SUNITINIBE | 50 MG CAP DURA CT FR PLAS PEAD OPC X 28 | Wholesale price without vat |
$0-0 |
$0-0 |
n/a | NATCOFARMADOBRASILLTDA |
| Brasil | (L01EX01) sunitinib (adm: O) | MALATO DE SUNITINIBE | 50 MG CAP DURA CT BL AL PLAS PVC/PCTFE TRANS X 28 | Wholesale price without vat |
$0-0 |
$0-0 |
n/a | SUNFARMACÊUTICADOBRASILLTDA |
| Brasil | (L01EX01) sunitinib (adm: O) | SARRA | 50 MG CAP DURA CT BL AL PLAS PVC/PCTFE TRANS X 28 | Wholesale price without vat |
$0-0 |
$0-0 |
n/a | SUNFARMACÊUTICADOBRASILLTDA |
| Brasil | (L01EX01) sunitinib (adm: O) | SUTENT | 50 MG CAP DURA CT FR PLAS PEAD OPC X 28 | Wholesale price without vat |
$0-0 |
$0-0 |
Gastrointestinal Stromal Tumors;Carcinoma, Renal Cell;Neuroendocrine Tumors | PFIZERBRASILLTDA |
| Brasil | (L01EX02) sorafenib (adm: O) | NEXAVAR | 200 MG COM REV CT BL AL / AL X 60 | Wholesale price without vat |
$0-0 |
$0-0 |
Carcinoma, Hepatocellular;Carcinoma, Renal Cell | BAYERS.A. |
| Brasil | (L01EX02) sorafenib (adm: O) | SOFANYR | 200 MG COM REV CT BL AL AL X 10 | Wholesale price without vat |
$0-0 |
$0-0 |
n/a | ACCORDFARMACÊUTICALTDA |
| Brasil | (L01EX02) sorafenib (adm: O) | SOFANYR | 200 MG COM REV CT BL AL AL X 30 | Wholesale price without vat |
$0-0 |
$0-0 |
n/a | ACCORDFARMACÊUTICALTDA |
| Brasil | (L01EX02) sorafenib (adm: O) | SOFANYR | 200 MG COM REV CT BL AL AL X 60 | Wholesale price without vat |
$0-0 |
$0-0 |
n/a | ACCORDFARMACÊUTICALTDA |
| Brasil | (L01EX02) sorafenib (adm: O) | TOSILATO DE SORAFENIBE | 200 MG COM REV CT BL AL AL X 10 | Wholesale price without vat |
$0-0 |
$0-0 |
n/a | ACCORDFARMACÊUTICALTDA |
| Brasil | (L01EX02) sorafenib (adm: O) | TOSILATO DE SORAFENIBE | 200 MG COM REV CT BL AL AL X 30 | Wholesale price without vat |
$0-0 |
$0-0 |
n/a | ACCORDFARMACÊUTICALTDA |
| Brasil | (L01EX02) sorafenib (adm: O) | TOSILATO DE SORAFENIBE | 200 MG COM REV CT BL AL AL X 60 | Wholesale price without vat |
$0-0 |
$0-0 |
n/a | ACCORDFARMACÊUTICALTDA |
| Brasil | (L01EX03) pazopanib (adm: O) | VOTRIENT | 200 MG COM REV CT FR PLAS OPC X 30 | Wholesale price without vat |
$0-0 |
$0-0 |
Carcinoma, Renal Cell | NOVARTISBIOCIENCIASS.A |
| Brasil | (L01EX03) pazopanib (adm: O) | VOTRIENT | 400 MG COM REV CT FR PLAS OPC X 60 | Wholesale price without vat |
$0-0 |
$0-0 |
Carcinoma, Renal Cell | NOVARTISBIOCIENCIASS.A |
| Brasil | (L01EX03) pazopanib (adm: O) | VOTRIENT | 400 MG COM REV CT FR PLAS OPC X 30 | Wholesale price without vat |
$0-0 |
$0-0 |
Carcinoma, Renal Cell | NOVARTISBIOCIENCIASS.A |
| Brasil | (L01EX04) vandetanib (adm: O) | CAPRELSA | 100 MG COM REV CT BL AL PLAS TRANS X 30 | Wholesale price without vat |
$0-0 |
$0-0 |
Thyroid Neoplasms | SANOFIMEDLEYFARMACÊUTICALTDA. |
| Brasil | (L01EX04) vandetanib (adm: O) | CAPRELSA | 300 MG COM REV CT BL AL PLAS TRANS X 30 | Wholesale price without vat |
$0-0 |
$0-0 |
Thyroid Neoplasms | SANOFIMEDLEYFARMACÊUTICALTDA. |
| Brasil | (L01EX05) regorafenib (adm: O) | STIVARGA | 40 MG COM REV CT FR PLAS OPC X 84 | Wholesale price without vat |
$0-0 |
$0-0 |
Colorectal Neoplasms | BAYERS.A. |
| Brasil | (L01EX07) cabozantinib (adm: O) | CABOMETYX | 20 MG COM REV CT FR PLAS PEAD OPC X 30 | Wholesale price without vat |
$0-0 |
$0-0 |
Carcinoma, Renal Cell;Carcinomas, Hepatocellular | BEAUFOURIPSENFARMACÊUTICALTDA |
Pages
